| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Ayala Pharmaceuticals (NASDAQ:AYLA) reported its Q3 earnings results on Friday, November 4, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Ayala Pharmaceuticals missed estimated earnings by 34.69%, reporting an EPS of $-0.66 versus an estimate of $-0.49.
Revenue was down $534 thousand from the same period last year.
Last quarter the company beat on EPS by $0.07 which was followed by a 8.0% increase in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Ayala Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: AYLA
